Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 200 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or guaranteed volume is provided. The commercial benefit is entirely dependent on the number of pres...

The open-house agreement automatically ceases if a formal discount contract for the same active substance is concluded...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products with active substances Formoterol and Aclidiniumbromid (ATC R03AL05)
  • Open-house model: no selection, all eligible companies can participate
Show full summary

This is an open-house model (not a formal tender) by AOK Bayern for non-exclusive discount agreements on pharmaceutical products with active substances Formoterol and Aclidiniumbromid (ATC R03AL05). All interested pharmaceutical companies that meet the eligibility criteria can enter into identical, non-negotiable agreements. The earliest contract start is 01.05.2025, and all contracts end on 30.04.2027. Contracts can be concluded at any time until 05.03.2027. The notice is published for transparency but is not subject to procurement law. No estimated value is provided.

Risks

No estimated value or guaranteed volume is provided. The commercial benefit is entirely dependent on the number of pres...

The open-house agreement automatically ceases if a formal discount contract for the same active substance is concluded...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible

Administrative

  • Must submit a signed self-declaration of reliability
  • Must submit the signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05

Non-exclusive discount agreements for pharmaceutical products containing Formoterol and Aclidiniumbromid (ATC R03AL05). All interested pharmaceutical companies can join under identical terms.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 05, 2027

Procurement Details

Publication date
18 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
178186-2025

Documents (2)

Similar tenders